Viewing Study NCT04344795


Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2025-12-30 @ 11:31 AM
Study NCT ID: NCT04344795
Status: COMPLETED
Last Update Posted: 2025-09-12
First Post: 2020-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors
Sponsor: Tempest Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module